Ivax Signs Distribution Agreement With Augurix

IVAX has signed a distribution agreement with Augurix for Simtomax Blood Drop, a test that diagnoses celiac disease in all patients.

As part of the agreement, IVAX will distribute Simtomax Blood Drop, through its Delta Biologicals division, to doctors in countries like Italy, UK, France, Spain, Germany, Portugal, the Netherlands, Belgium, Greece, Romania, Turkey and Saudi Arabia.

The company said that the patients will be able to detect the presence of the disease within ten minutes.

Charles Struby, CEO of IVAX Diagnostics, said: “Augurix’s patented Simtomax platform is a unique and novel immunochromatography-based technology that allows for several analyses to be performed simultaneously. The test is easy to use, requires no medical skills or training, is non-invasive and provides rapid and clear results, all factors that add to its appeal for screening.”

“Our sales force in Europe and Asia will help place this test into the hands of doctors and ultimately patients who can benefit from detection of celiac disease, which is considered to be the most under-diagnosed condition in the world. Augurix has developed an effective platform technology, and we look forward to partnering with them to make their product available to patients who are afflicted with celiac disease,” he added.